Crown Wealth Group
ABBV icon

Crown Wealth Group’s AbbVie ABBV Stock Holding History

Crown Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$711K Buy
2,718
+158
+6% +$40.5K 0.18% 67
2026
Q2 		$644K Buy
2,560
+5
+0.2% +$1.08K 0.16% 64
2026
Q1 		$556K Buy
2,555
+115
+5% +$25.5K 0.16% 63
2025
Q4 		$558K Buy
2,440
+277
+13% +$63.1K 0.16% 63
2025
Q3 		$501K Buy
2,163
+8
+0.4% +$1.63K 0.15% 67
2025
Q2 		$400K Buy
2,155
+94
+5% +$17.5K 0.15% 69
2025
Q1 		$432K Buy
2,061
+110
+6% +$21.4K 0.22% 55
2024
Q4 		$347K Buy
1,951
+45
+2% +$8.27K 0.14% 75
2024
Q3 		$376K Sell
1,906
-48
-2% -$8.96K 0.16% 71
2024
Q2 		$335K Buy
1,954
+100
+5% +$16.6K 0.17% 71
2024
Q1 		$338K Buy
1,854
+545
+42% +$93.9K 0.17% 64
2023
Q4 		$203K Buy
+1,309
New +$191K 0.12% 92

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Crown Wealth Group's ABBV Position: Q3 2026 in Review

Crown Wealth Group increased its AbbVie (ABBV) stake by 6.2% in Q3 2026, buying an estimated $40.5K and bringing the position to 2,718 shares worth $711K. The position accounts for 0.18% of the portfolio, ranked #67.

Crown Wealth Group first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Crown Wealth Group held 2,718 shares of AbbVie worth $711K as of Q3 2026.
  • Crown Wealth Group bought 158 AbbVie shares in Q3 2026, an estimated $40.5K.
  • AbbVie made up 0.18% of Crown Wealth Group's portfolio in Q3 2026, its #67 holding.
  • Crown Wealth Group first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Crown Wealth Group's 13F filing for Q3 2026, filed 19 Oct 2026.